Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California. Show more
Location: 701 Anacapa Street, Santa Barbara, CA, 93101, United States | Website: https://phytanix.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
1.135M
52 Wk Range
$0.26 - $14.28
Previous Close
$0.66
Open
$0.66
Volume
44,621
Day Range
$0.59 - $0.72
Enterprise Value
2.475M
Cash
2.722M
Avg Qtr Burn
N/A
Insider Ownership
3.59%
Institutional Own.
6.08%
Qtr Updated
09/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
PT00114 Details Major depression, anxiety disorders, PTSD, addiction / substance use disorders | Phase 2 Initiation |
